Civitas Therapeutics Initiates Phase 2b Clinical Study of CVT-301, inhaled L-dopa for Parkinson’s Disease by longitudeadmin | Sep 5, 2013 | Portfolio News
Collegium Pharmaceutical’s Oxycodone DETERx(R), an Abuse-Deterrent, Extended-Release Opioid, to be featured at PAINWeek 2013 by longitudeadmin | Sep 3, 2013 | Portfolio News
Esperion Therapeutics Announces Positive Top-Line Results from Phase 2 Clinical Study of ETC-1002 as an Add-On to Statin Therapy in Patients with Hypercholesterolemia by longitudeadmin | Sep 3, 2013 | Portfolio News
Ovarian Cancer Chemoresponse Assay Demonstrates Utility by longitudeadmin | Aug 20, 2013 | Portfolio News
